Skip to content

Newsroom

Order our news

Would you like to be included on our distribution list for our news? We would be happy to provide you with our latest press releases and short news by e-mail. This service is free of charge and may be cancelled at any time.

You can cancel this free service at any time by sending an e-mail to ir(at)fmc-ag.com, or by calling +49 (0) 6172 - 609 2525.

The information you provide will only be used to answer your query. For more information on how we process your Personal Data please read our privacy policy.

newsletter registration

captcha
| Short News
Fresenius Medical Care expands value-based care in the U.S.
Fresenius Medical Care North America announced today partnerships with more than 1,000 nephrology providers in the U.S. as part of the new Kidney Care Choices (KCC) models.
| Short News
Fresenius Medical Care with top result in climate ranking
In this year's ranking, the non-profit organization CDP has confirmed Fresenius Medical Care' classification.
| Press release
Fresenius Medical Care announces changes to Management Board, reflecting the transformation to the company’s new operating model
Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, today announced changes to the Management Board effective on January 1, 2022.
| Press release
Fresenius Medical Care confirms outlook for 2021 while considering the continued negative impact of COVID-19
Stronger than projected headwind from COVID-19 effects with significantly increased patient excess mortality due to global spread of Delta variant
| Press release
Fresenius Medical Care transforms its operating model, entering the next phase of its 2025 growth strategy
Fresenius Medical Care continues to execute on its growth strategy 2025 launched in October 2020.
1 2 3 ... 23
Related content

Do you have any questions? Contact us!

Fresenius Medical Care is the world’s leading provider of dialysis products and services. Find out more about the company’s key facts and innovations.